revlit format

8/13/2019 Revlit Format

1/6

AUTHOR/S, DATE

PUBLISHED;

JOURNAL NAME

TITLE OF THE STUDY MAJOR OBJECTIVES DELINEATED

FACTORS

LOCUS METHOD

de Frana ND,Poli

MC,Ramos PG,Borsoi CS,Colella R

(2011). Rev Bras

Hematol Hemoter

Titers of ABO

antibodies in group Oblood donors.

Group O donations

stratified by genderand age were

randomly titrated to

identify the best

source of products

for apheresis and

exsanguinous

transfusion.

Age, gender, blood

group O

Banco de Sangue de

So Paulo, So Paulo,SP, Brazil.

Antibody titration

(conventional tubetechnique)

Statistics: the Fisher

exact and Kruskal-

Wallis tests.

Mair B, Benson K.

(1998). Transfusion.

Evaluation of changes

in hemoglobin levels

associated with ABO-

incompatible plasma

in apheresis platelets.

To identify possible

hemolysis related to

the transfusion of

plasma-incompatible

apheresis platelets.

Transfusion of

plasma-incompatible

apheresis platelets

(minor ABO

incompatibility),

hemoglobin levels

Department of

Pathology and

Laboratory Medicine,

University of South

Florida College of

Medicine, Tampa,

USA.

Determination of

Pretransfusion and

posttransfusion

hemoglobin levels

Rao, P.; Joshi, S.

(2007). Asian Journal

of Transfusion

Science

Determination of

ABO titre for pheresis

platelet transfusion

To determine ABO

titre for pheresis

platelet transfusion

Unexposed to

platelets and

undergoing

treatment for acute

leukemia and

thalassemia or BMT,

transfusedleucodepleted

platelets,

Platelet transfusion

refractoriness

B-9, Kanara Business

Centre, Off Link Road,

Ghatkopar (E),

Mumbai - 400075,

INDIA

Platelet transfusion

refractoriness
http://www.ncbi.nlm.nih.gov/pubmed?term=de%20Fran%C3%A7a%20ND%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Poli%20MC%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Poli%20MC%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Ramos%20PG%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Borsoi%20CS%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Colella%20R%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Colella%20R%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Borsoi%20CS%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Ramos%20PG%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Poli%20MC%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=Poli%20MC%5BAuthor%5D&cauthor=true&cauthor_uid=23049315http://www.ncbi.nlm.nih.gov/pubmed?term=de%20Fran%C3%A7a%20ND%5BAuthor%5D&cauthor=true&cauthor_uid=23049315


2/6

Dong II Won; Byung

Chang Kim

(2012). Laboratory

Medicine

Optimized Flow

Cytometry to

Measure Anti-ABO

Immunoglobulin G

Accurate

measurement of ABO

antibody levels

before and after ABO-

incompatible organ

transplantations.

Mean fluorescence

intensity (MFI) ratio,

Anti-ABO IgG,

Residual

hemagglutination and

hemolysis,

American Society for

Clinical Pathology

33 W Monroe, #1600

Chicago, IL 6060

Optimized Flow

Cytometry

[Flow ABO Ab and the

column agglutination

technique (CAT)]

Karafin MS,Blagg L,

Tobian AA,King KE,

Ness PM,Savage

WJ.(2012).

Transfusion

ABO antibody titers

are not predictive of

hemolytic reactions

due to plasma-

incompatible platelet

transfusions.

To evaluate all

apheresis PLT (AP)

transfusions for 3

months.; to

determined the anti-

A and/or the anti-B

immunoglobulin (Ig)G

titer for allincompatible APs.

Apheresis PLT (AP)

transfusion

[anti-A and/or the

anti-B

immunoglobulin (Ig)G

titer for all

incompatible APs];

Posttransfusion directantiglobulin test

(DAT) and eluate

Department of

Pathology, Johns

Hopkins University,

Baltimore, Maryland,

USA.

Gel titer method

Submitted by: Valdez, Dennis Bryan A.
http://www.ncbi.nlm.nih.gov/pubmed?term=Karafin%20MS%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=Blagg%20L%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=Tobian%20AA%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=King%20KE%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=Ness%20PM%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=Ness%20PM%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=King%20KE%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=Tobian%20AA%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=Blagg%20L%5BAuthor%5D&cauthor=true&cauthor_uid=22339320http://www.ncbi.nlm.nih.gov/pubmed?term=Karafin%20MS%5BAuthor%5D&cauthor=true&cauthor_uid=22339320


3/6

AUTHOR/S, DATE

PUBLISHED;

JOURNAL NAME


FACTORS

LOCUS METHOD

M. Libich (1961).

Immunology.

Immunochemical

Titration of Antigens

and Antibodies in

Electric Field: Titration

of Antigens in Complex

Systems and Titration of

Individual Determinant

Antigen Groups

To develop a

quantitative

immunochemical

method suitable for

titration of antigens

and antibodies in

complex systems.

Antigenic

components in crude

diphtheria toxin and

tetanus toxoid

Vintage House, 37

Albert Embankment,

London SE1 7TL

A quantitative

immunochemical

method

Bobrovnik SA.

(2012).

Ukr Biokhim Zh.

Analysis of titration

curves of serum

antibodies obtained by

ELISA

New interpretation

of dose-dependent

titration curves

serum antibodies,

monoclonal

antibodies and

polyreactive

immunoglobulins

Russia ELISA

Daniel-Johnson J,

Leitman S,Klein H,

Alter H,Lee-Stroka

A,Scheinberg P,

Pantin J,Quillen K.

(2009).

Transfusion.

Probiotic-associated

high-titer anti-B in a

group A platelet donor

as a cause of severe

hemolytic transfusion

reactions.

To determine

Hemolytic

transfusion reactions

(HTRs) along with

transfusion of

platelets (PLTs)

containing ABO-

incompatible plasma.

Plateletpheresis

component,

Transfusion of

platelets (PLTs),

ABO-incompatible

plasma

Department of

Pathology, Johns

Hopkins University,


USA.

Plateletpheresis

component

determination

Shirey,R.S., Cai, W.,

Montgomery R.A.,Chhibber, V., Ness,

P.M., & King, K.E.

(2009). Transfusion.

IMMUNOHEMATOLOGY:

Streamlining ABOantibody titrations for

monitoring ABO-

incompatible kidney

transplants

To monitor ABO

antibody titers in 53ABO-incompatible

kidney transplants

(INKTs)

Anti-A and/or anti-B

anti-human globulin(AHG) titers

Department of

Pathology, JohnsHopkins University,


USA.

Revised test tube (TT)

method without RT;anti-immunoglobulin

G (IgG) gel

microcolumn (IgG

gel)
http://www.ncbi.nlm.nih.gov/pubmed/?term=Libich%20M%5Bauth%5Dhttp://www.ncbi.nlm.nih.gov/pubmed?term=Bobrovnik%20SA%5BAuthor%5D&cauthor=true&cauthor_uid=22642128http://www.ncbi.nlm.nih.gov/pubmed/22642128http://www.ncbi.nlm.nih.gov/pubmed?term=Daniel-Johnson%20J%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Leitman%20S%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Klein%20H%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Alter%20H%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Lee-Stroka%20A%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Lee-Stroka%20A%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Scheinberg%20P%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Pantin%20J%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Quillen%20K%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Quillen%20K%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Pantin%20J%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Scheinberg%20P%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Lee-Stroka%20A%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Lee-Stroka%20A%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Alter%20H%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Klein%20H%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Leitman%20S%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed?term=Daniel-Johnson%20J%5BAuthor%5D&cauthor=true&cauthor_uid=19453987http://www.ncbi.nlm.nih.gov/pubmed/22642128http://www.ncbi.nlm.nih.gov/pubmed?term=Bobrovnik%20SA%5BAuthor%5D&cauthor=true&cauthor_uid=22642128http://www.ncbi.nlm.nih.gov/pubmed/?term=Libich%20M%5Bauth%5D


4/6

Ata P,Cetinkaya F,

Ozgezer T,Ozel L,

Tulunay A,Eksioglu

E,Titiz MI.(2012).

Transplant Proc.

Flow cytometric

detection of anti-AB

antibody titers in blood

group O recipients of

blood group A2 donor

kidneys.

To analyze 20 living

related renal

transplant couples to

detect recipient anti-

A2 antibody

Flow cytometric

antibody titers

Blood groups

subtype,

Anti-A2 antibody

titers,

Department of

Molecular Genetics,

Haydarpasa Numune

Research and

Training Hospital,

Genetic Diseases

Diagnosis Center,

Turkey.

Flow cytometric

analysis;

lectin-based dilution

assay;

hemagglutination

method

Submitted by: Paltep, Rashell Anne C.
http://www.ncbi.nlm.nih.gov/pubmed?term=Ata%20P%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Cetinkaya%20F%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Ozgezer%20T%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Ozel%20L%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Tulunay%20A%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Eksioglu%20E%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Eksioglu%20E%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Titiz%20MI%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed/22841249http://www.ncbi.nlm.nih.gov/pubmed/22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Titiz%20MI%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Eksioglu%20E%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Eksioglu%20E%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Tulunay%20A%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Ozel%20L%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Ozgezer%20T%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Cetinkaya%20F%5BAuthor%5D&cauthor=true&cauthor_uid=22841249http://www.ncbi.nlm.nih.gov/pubmed?term=Ata%20P%5BAuthor%5D&cauthor=true&cauthor_uid=22841249


5/6

AUTHOR/S, DATE

PUBLISHED;

JOURNAL NAME


FACTORS

LOCUS METHOD

A. RICHARDSON

JONES and

LORRAINE KANEB.

(1960). Blood

Some Properties Of Cross

Reacting Antibody Of The

ABO Blood Group System

-to determine the

spatial relationship

between the site of

action of the cross

reacting antibody in

group 0 serum

and the antigens A or

B of the cell.

-establish the

relationship between

the titer of cross

reacting antibody inthe serum of group 0

pregnant women and

the subsequent

development of

erythroblastosis in

their newborn

infants.

cross reacting

property of group 0

American Society of

Hematology, 2021 L

St, NW, Suite 900,

Washington DC

mixed agglutination

technic for directly

demonstrating the

adherence of two

cells of differing

specificity by cross

reacting antibody


6/6

Paul R. Warner, PhD,

and Theresa A.

Nester.(2006)

Am J Clin Pathol

(ASCP)

ABO-Incompatible Solid-

Organ Transplantation

To increase

transplantation

access, particularly in

living-donor renal

transplantation,

efforts have been

made to overcome

the barrier of ABO

incompatibility

- expression of

antigen on the graft,

positive organs;

- low titer of

antidonor ABO

antibodies in the

recipient before

transplantation

- ability to maintain

low titers of

antidonor ABO

antibodies in the

recipient after

transplantation

American Society for

Clinical Pathology

- renal

transplantation

- Peritransplantation

N. D. deFrana,M.C.

Poli,P.G. de AlmeidaRamos,C.D.R.

S.Borsoi,R. Colella

(2011). Revista

brasileira de

hematologia e

hemoterapia

Titers of ABO antibodies in

group O blood donors.

to identify the best

source of productsfor apheresis and

exsanguinous

transfusion.

group O donations

stratified by genderand age were

randomly titrated

Banco de Sangue de

So Paulo, So Paulo,SP, Brazil.

ABO antibodytitrations

A. A. R. Tobian, R. S.

Shirey, R. A.

Montgomery, W. Cai,

M. Haas, P. M. Nessand K. E. King. 2010

American Journal of

Transplantation

ABO Antibody Titer and

Risk of Antibody-Mediated

Rejection in ABO-

Incompatible RenalTransplantation

To evaluate 46

individuals who

received TPE to

permit ABO-I kidneytransplantatio.

-characteristics of

individuals with and

without antibody-

mediated rejection(AMR), and elevated

titers

-posttransplant ABO

antibody titer and

the correlation to

antibody-mediated

rejection

Johns Hopkins

Medical Institutions,

Baltimore, MD

Cedars-Sinai Medical

Center, Los Angeles,

CA

- Human leukocyte

antigen (HLA)

crossmatch

techniques- flow cytometry with

T and B cells

-histopathologic

analysis of biopsies

and diagnosis of

rejection
http://www.researchgate.net/researcher/2001344803_Natalia_Dallaval_Galvao_de_Franca/http://www.researchgate.net/researcher/31622902_Monica_Caamano_Cristovao_Poli/http://www.researchgate.net/researcher/31622902_Monica_Caamano_Cristovao_Poli/http://www.researchgate.net/researcher/2001347572_Patricia_Guilhem_de_Almeida_Ramos/http://www.researchgate.net/researcher/2001347572_Patricia_Guilhem_de_Almeida_Ramos/http://www.researchgate.net/researcher/2001338030_Claudia_Strang_da_Rocha_Borsoi/http://www.researchgate.net/researcher/2001338030_Claudia_Strang_da_Rocha_Borsoi/http://www.researchgate.net/researcher/15029616_Rafael_Colella/http://www.researchgate.net/researcher/15029616_Rafael_Colella/http://www.researchgate.net/researcher/2001338030_Claudia_Strang_da_Rocha_Borsoi/http://www.researchgate.net/researcher/2001338030_Claudia_Strang_da_Rocha_Borsoi/http://www.researchgate.net/researcher/2001347572_Patricia_Guilhem_de_Almeida_Ramos/http://www.researchgate.net/researcher/2001347572_Patricia_Guilhem_de_Almeida_Ramos/http://www.researchgate.net/researcher/31622902_Monica_Caamano_Cristovao_Poli/http://www.researchgate.net/researcher/31622902_Monica_Caamano_Cristovao_Poli/http://www.researchgate.net/researcher/2001344803_Natalia_Dallaval_Galvao_de_Franca/

revlit format

Documents